Document is current

Article History

Received: 4 September 2025

Accepted: 22 June 2026

First Online: 25 June 2026

Declarations

:

: This study is a literature review of previously published work and did not involve the collection of primary data from human participants or animals; therefore, ethics approval and consent to participate were not required.

: Not applicable.

: The authors are current or former employees of Otsuka Precision Health, which develops and commercializes prescription digital therapeutics, including Rejoyn. The authors have no other financial or non-financial competing interests to declare.